Evidence map›Paper›PMID 30866482›Full record

ArticleJournal of clinical medicine2019

Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment.

Carlos Llanes, Ana I Álvarez, M Teresa Pastor, M Ángeles Garzón, Nerea González-García, Ángel L Montejo

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Carlos LlanesDepartment of Psychiatry, Complejo Asistencial de Zamora, Zamora 49022, Spain. cllanes@saludcastillayleon.es.ORCID 0000-0002-7094-0511
Ana I ÁlvarezDepartment of Psychiatry, Hospital Clínico Universitario de Salamanca, Salamanca 37007, Spain. aialvarez@saludcastillayleon.es.
M Teresa PastorCastilla y León Health Authority, Complejo Asistencial de Zamora, Zamora 49022, Spain. mtpastor@saludcastillayleon.es.
M Ángeles GarzónDepartment of Psychiatry, Hospital Clínico Universitario de Salamanca, Salamanca 37007, Spain. magarzon@saludcastillayleon.es.
Nerea González-GarcíaDepartment of Statistics, University of Salamanca, Institute of Biomedical Research of Salamanca IBSAL, Salamanca 37007, Spain. nerea_gonzalez_garcia@usal.es.ORCID 0000-0002-2814-2807
Ángel L MontejoPsychiatry, University of Salamanca, Institute of Biomedical Research of Salamanca IBSAL, Salamanca 37007, Spain. amontejo@usal.es.ORCID 0000-0003-4383-1333
Complejo Hospitalario de Salamanca · ESHospital Virgen de la Concha · ESUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined whether methadone (hereinafter referred to as MTD) maintenance treatment (MMT) is correlated with sexual dysfunction (SD) in heroin-dependent men. This was conducted to determine the prevalence of sexual dysfunction and if there is a relationship between duration and dose among men on MMT and its impact on the quality of life. The study combined a retrospective and a cross-sectional survey based on the Kinsey Scale, TECVASP, and PRSexDQ-SALSEX clinical interviews of 85 patients who are currently engaged in MMT. Sexual dysfunction in all five PRSexDQ-SALSEX domains (lack of libido, delay in orgasm, inability to orgasm, erectile dysfunction, and tolerance or acceptance of changes in sexual function) was associated with dose and long-term use of heroin. All dimensions of SD were affected by the MTD intake. From the analysis of our sample, we may conclude that dose of MTD and overall score of SD were directly associated. However, no evidence was found to prove that treatment duration and severity of SD were linked. It is notable that only one tenth of the patients spontaneously reported their symptoms of the sexual sphere, but up to a third considered leaving the MMT for this reason.

Indexed as

adverse effectserectile dysfunctionmedication adherencemethadoneopioid-related disorders

Identifiers

PMID30866482
PMCPMC6463066
OpenAlexW2918410349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.